Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for pediatric outpatient strabismus surgery anesthesia
ChiCTR2400094883Phase 4Not yet recruiting
- Sponsor
- Maternal and Child Health Hospital of Hubei Province
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in strabismus (2 arms), sponsored by Maternal and Child Health Hospital of Hubei Province. Primary endpoints: blood pressure, oxygen saturation and 3 more. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
strabismus
Beyond the preview
Go deeper on ChiCTR2400094883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094883.